Items where Author is "Thimme, R."

Article

Illert, A. L. and Stenzinger, A. and Bitzer, M. and Horak, P. and Gaidzik, V. I. and Moeller, Y. and Beha, J. and Oener, Oe and Schmitt, F. and Lassmann, S. and Ossowski, S. and Schaaf, C. P. and Hallek, M. and Bruemmendorf, T. H. and Albers, P. and Fehm, T. and Brossart, P. and Glimm, H. and Schadendorf, D. and Bleckmann, A. and Brandts, C. H. and Esposito, I and Mack, E. and Peters, C. and Bokemeyer, C. and Froehling, S. and Kindler, T. and Alguel, H. and Heinemann, V and Doehner, H. and Bargou, R. and Ellenrieder, V. and Hillemanns, P. and Lordick, F. and Hochhaus, A. and Beckmann, M. W. and Pukrop, T. and Trepel, M. and Sundmacher, L. and Wesselmann, S. and Nettekoven, G. and Kohlhuber, F. and Heinze, O. and Budczies, J. and Werner, M. and Nikolaou, K. and Beer, A. J. and Tabatabai, G. and Weichert, W. and Keilholz, U. and Boerries, M. and Kohlbacher, O. and Duyster, J. and Thimme, R. and Seufferlein, T. and Schirmacher, P. and Malek, N. P. (2023) The German Network for Personalized Medicine to enhance patient care and translational research. NATURE MEDICINE, 29 (6). pp. 1298-1301. ISSN 1078-8956, 1546-170X

Huzly, D. and Umhau, M. and Bettinger, D. and Cathomen, T. and Emmerich, F. and Hasselblatt, P. and Hengel, H. and Herzog, R. and Kappert, O. and Maassen, S. and Schorb, E. and Schulz-Huotari, C. and Thimme, R. and Unmuessig, R. and Wenzel, J. J. and Panning, M. (2014) Transfusion-transmitted hepatitis E in Germany, 2013. EUROSURVEILLANCE, 19 (21): 20812. pp. 11-14. ISSN 1560-7917

Other

Sprinzl, M. and Grambihler, A. and Teuber, G. and Antoni, C. and Zeuzem, S. and Discher, T. and Cornberg, M. and Berg, T. and Loehr, H. and Tacke, F. and Lammert, F. and Schott, E. and Berg, C. and Zizer, E. and Heyne, R. and Spengler, U. and Thimme, R. and Pathil, A. and Klinker, H. and Weigand, K. and Riedl, M. and Wosniok, J. and Alshuth, U. and Kittner, J. and Schuchmann, M. and Galle, P. R. (2018) Addition of pegylated interferon alfa-2a to an ongoing nucleos(t) ide treatment accelerates decrease of HBs-antigen levels in patients with chronic hepatitis B: Results from the PADD-ON study. ELSEVIER SCIENCE BV, AMSTERDAM.

Dietz, J. and Vermehren, J. and Susser, S. and Peiffer, K. -H. and Welzel, T. and Wursthorn, K. and Petersen, J. and Klinker, H. and Wiesch, J. S. Z. and Hinrichsen, H. and Discher, T. and Reinhardt, L. and Mauss, S. and Mueller-Schilling, M. and Niederau, C. and Neumann-Haefelin, C. and Thimme, R. and Berg, C. and Zeuzem, S. and Sarrazin, C. (2018) NS5A resistance patterns and treatment outcomes in DAA-naive genotype 1a chronic hepatitis C patients with and without baseline resistance-associated substitutions. ELSEVIER SCIENCE BV, AMSTERDAM.

Sprinzl, M. F. and Grambihler, A. and Teuber, G. and Ebert, M. and Zeuzem, S. and Lohmeyer, J. and Cornberg, M. and Tacke, F. and Loehr, H. and Berg, T. and Lammert, F. and Schott, E. and Heyne, R. and Berg, C. and Dollinger, M. and Pathil-Warth, A. and Geisler, F. and Spengler, U. and Thimme, R. and Weigand, K. and Alshuth, U. and Ehrlich, A. and Riedl, M. and Kittner, J. and Schuchmann, M. and Galle, P. R. (2016) ADD ON INTERFERON-ALPHA-2A FOR THE TREATMENT OF HBEAG NEGATIVE HEPATITIS B PATIENTS RECEIVING EFFECTIVE NUCLEOS (T)IDE THERAPY: INTERIM RESULTS OF THE PROSPECTIVE MULTICENTRE PADD-ON TRIAL. ELSEVIER SCIENCE BV, AMSTERDAM.